Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors.

Lombardi Fäh V, Del Vento F, Intidhar Labidi-Galy S, Undurraga M

DOI: 10.1016/j.gore.2024.101531
Published: 2024 Dec
Container: Gynecologic oncology reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.gore.2024.101531,
  title = {Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors.},
  author = {Lombardi Fäh V and Del Vento F and Intidhar Labidi-Galy S and Undurraga M},
  year = {2024},
  journal = {Gynecologic oncology reports},
  doi = {10.1016/j.gore.2024.101531},
  url = {https://doi.org/10.1016/j.gore.2024.101531}
}

RIS

TY  - JOUR
TI  - Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors.
AU  - Lombardi Fäh V
AU  - Del Vento F
AU  - Intidhar Labidi-Galy S
AU  - Undurraga M
PY  - 2024
JO  - Gynecologic oncology reports
DO  - 10.1016/j.gore.2024.101531
UR  - https://doi.org/10.1016/j.gore.2024.101531
ER  -

APA

V, L. F., F, D. V., S, I. L., & M, U. (2024). Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors.. Gynecologic oncology reports. https://doi.org/10.1016/j.gore.2024.101531

Source records

pubmed · retrieved 2026-09-25T11:34:38.213Z